AIM
VRTX icon

AIA Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

AIA Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$536K Buy
1,968
+490
+33% +$135K 0.12% 103
2020
Q2 		$429K Buy
+1,478
New +$401K 0.1% 83

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AIA Investment Management's VRTX Position: Q3 2020 in Review

AIA Investment Management increased its Vertex Pharmaceuticals (VRTX) stake by 33% in Q3 2020, buying an estimated $135K and bringing the position to 1,968 shares worth $536K. The position accounts for 0.12% of the portfolio, ranked #103.

AIA Investment Management first reported a position in VRTX in Q2 2020 and has held it in 2 quarters since. 950 funds tracked by Wall St. Rank hold VRTX as of Q3 2020.

  • AIA Investment Management held 1,968 shares of Vertex Pharmaceuticals worth $536K as of Q3 2020.
  • AIA Investment Management bought 490 Vertex Pharmaceuticals shares in Q3 2020, an estimated $135K.
  • Vertex Pharmaceuticals made up 0.12% of AIA Investment Management's portfolio in Q3 2020, its #103 holding.
  • AIA Investment Management first reported a position in Vertex Pharmaceuticals in Q2 2020 and has held it in 2 quarters since.
  • 950 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2020.

Based on AIA Investment Management's 13F filing for Q3 2020, filed 16 Nov 2020.